Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 1993; Volume 266,Issue 1
  • You have access
    Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    C S Cook, C Hauswald, J A Oppermann and G L Schoenhard
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 1-7;
  • You have access
    Common phosphatidylinositol 4,5-bisphosphate pools are involved in carbachol and serotonin activation of tracheal smooth muscle.
    C B Baron, J Pompeo, D Blackman and R F Coburn
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 8-15;
  • You have access
    Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart.
    R C Gupta, J Neumann and A M Watanabe
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 16-22;
  • You have access
    Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
    T A Glauser, A N Nelson, D E Zembower, J J Lipsky and R M Weinshilboum
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 23-32;
  • You have access
    Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    M Bak, M Shalmi, J S Petersen, L B Poulsen and S Christensen
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 33-40;
  • You have access
    Cocaine enhances postrest and paired-stimulation potentiation in rat papillary muscle.
    R G Carpentier, B R Coleman and D J Patel
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 41-46;
  • You have access
    Intracellular calcium mediates the cytotoxicity of lipid A in LLC-PK1 cells.
    P R Mayeux and S V Shah
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 47-51;
  • You have access
    Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.
    K Chiba, K Kobayashi, K Manabe, M Tani, T Kamataki and T Ishizaki
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 52-59;
  • You have access
    MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    H Ogura and T G Aigner
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 60-64;
  • You have access
    Electrogenic and electroneutral HCO3-secretion by guinea pig gallbladder epithelium: discriminatory abilities of Cl- channel blockers.
    K U Petersen, P Cormann, H J Macherey, G Sprakties and J M Winterhager
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 65-73;
  • You have access
    Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    M Kadowaki, Y Nagakura, M Tomoi, J Mori and M Kohsaka
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 74-80;
  • You have access
    Phenylbutazone peroxidatic metabolism and conjugation.
    V M Lakshmi, T V Zenser, M B Mattammal and B B Davis
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 81-88;
  • You have access
    Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.
    M Elhamri, B Ferrier, M Martin and G Baverel
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 89-96;
  • You have access
    Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    E Nisoli, C Tonello, R Imhof, R Scherschlicht, M da Prada and M O Carruba
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 97-105;
  • You have access
    Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.
    K M Standifer, J A Clark and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 106-113;
  • You have access
    Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Y Shibouta, Y Inada, M Ojima, T Wada, M Noda, T Sanada, K Kubo, Y Kohara, T Naka and K Nishikawa
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 114-120;
  • You have access
    Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    A E Takemori, H H Loh and N M Lee
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 121-124;
  • You have access
    Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
    M J Antonaccio, D Normandin, R Serafino and S Moreland
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 125-132;
  • You have access
    Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum.
    E A Johnson, C E Tsai, Y H Shahan and A J Azzaro
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 133-141;
  • You have access
    Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors.
    C Russo, M Marchi, G C Andrioli, P Cavazzani and M Raiteri
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 142-146;
  • You have access
    Central nervous and systemic kinetics of ramipril and ramiprilat in the conscious dog.
    M Nordström, T Abrahamsson, M Ervik, E Forshult and C G Regårdh
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 147-152;
  • You have access
    Enhancement of gamma-aminobutyric acidA receptor function and binding by the volatile anesthetic halothane.
    B Longoni, G C Demontis and R W Olsen
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 153-159;
  • You have access
    Purinergic P2y receptors stimulate renin secretion by rat renal cortical slices.
    P C Churchill and V R Ellis
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 160-163;
  • You have access
    Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
    D P Brooks, G Giardina, M Gellai, G Dondio, R M Edwards, G Petrone, P D DePalma, M Sbacchi, M Jugus and P Misiano
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 164-171;
  • You have access
    Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus.
    A J Barbier and R A Lefebvre
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 172-178;
  • You have access
    Acetylpolyamines decrease blood pressure, [Ca++]i and isometric force of vascular smooth muscle.
    L Y Wing, C F Chan and M J Jiang
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 179-183;
  • You have access
    Naloxone-induced potentiation of cardiac alpha-2 adrenoceptor-mediated depression of neurogenic tachycardia.
    K J Slavik and J E Szilagyi
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 184-191;
  • You have access
    Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    G Drapeau, R Audet, L Levesque, D Godin and F Marceau
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 192-199;
  • You have access
    Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
    H Mizumoto, A Karasawa and K Kubo
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 200-206;
  • You have access
    L-2-amino-4-phosphonobutanoic acid and 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid reduce paired-pulse depression recorded from medial perforant path in the dentate gyrus of rat hippocampal slices.
    J S Kahle and C W Cotman
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 207-215;
  • You have access
    Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.
    C Rundfeldt and W Löscher
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 216-223;
  • You have access
    Sodium nitroprusside stimulates anion secretion and inhibits sodium chloride absorption in rat colon.
    K T Wilson, Y Xie, M W Musch and E B Chang
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 224-230;
  • You have access
    Effects of Agelenopsis aperta toxins on the N-methyl-D-aspartate receptor: polyamine-like and high-affinity antagonist actions.
    K Williams
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 231-236;
  • You have access
    Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    S Z Wang and E E el-Fakahany
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 237-243;
  • You have access
    Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats.
    M Ekblom, M Hammarlund-Udenaes and L Paalzow
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 244-252;
  • You have access
    The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways.
    D H Wolsing and J S Rosenbaum
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 253-261;
  • You have access
    Protective effect of clentiazem against epinephrine-induced cardiac injury in rats.
    T A Deisher, H Narita, P Zera, R Ginsburg, M R Bristow, M E Billingham, M B Fowler and B B Hoffman
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 262-269;
  • You have access
    A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
    G Piedimonte, C Bertrand, P Geppetti, R M Snider, M C Desai and J A Nadel
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 270-273;
  • You have access
    The baroreceptor mechanism for controlling renin secretion: effect of calcium channel blockers.
    T Jones-Dombi and P Churchill
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 274-278;
  • You have access
    Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
    D Mohuczy-Dominiak and L C Garg
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 279-287;
  • You have access
    Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
    J W Lenders, R Kvetnansky, K Pacak, D S Goldstein, I J Kopin and G Eisenhofer
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 288-293;
  • You have access
    Direct evidence for the coupling of A2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum.
    R B Marala and S J Mustafa
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 294-300;
  • You have access
    Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
    M T Griffin, E A Thomas and F J Ehlert
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 301-305;
  • You have access
    Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
    D C Underwood, R R Osborn, L B Novak, J K Matthews, S J Newsholme, B J Undem, J M Hand and T J Torphy
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 306-313;
  • You have access
    Role of prostanoids in the regulation of central cholinergic receptor sensitivity.
    J J Buccafusco, C A Lapp, R S Aronstam, A C Hays and L C Shuster
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 314-322;
  • You have access
    Opioid-induced suppression of rat testicular function.
    M L Adams, B Sewing, J B Forman, E R Meyer and T J Cicero
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 323-328;
  • You have access
    Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    E T Iwamoto and L Marion
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 329-338;
  • You have access
    Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    S B Penner, D D Smyth and G B Glavin
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 339-343;
  • You have access
    A new prostacyclin analog, KP-10614, inhibits platelet-polymorphonuclear leukocyte interaction and limits experimental infarct size in rat heart.
    T Kanayama, Y Kimura and S Mizogami
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 344-349;
  • You have access
    Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum.
    S Ofori, O Bugnon and M Schorderet
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 350-357;
  • You have access
    Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
    J Galitzky, M Reverte, C Carpene, M Lafontan and M Berlan
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 358-366;
  • You have access
    Ca(++)-independent relaxation mediated by beta adrenoceptor in Ca(++)-independent contraction of uterine smooth muscle.
    T Ishine, Y Miyauchi and M K Uchida
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 367-373;
  • You have access
    Effects of diltiazem on calcium metabolism in cultured bovine glomerulosa cells: relationships to the actions of angiotensin II and potassium.
    R E Kramer
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 374-384;
  • You have access
    Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
    F Knoflach, U Drescher, L Scheurer, P Malherbe and H Mohler
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 385-391;
  • You have access
    The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    S Chakder and S Rattan
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 392-399;
  • You have access
    Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
    Y Liu, H Kreppel, J Liu, S Choudhuri and C D Klaassen
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 400-406;
  • You have access
    Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: protection against ventricular fibrillation.
    G E Billman
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 407-416;
  • You have access
    Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors.
    B A Fuchs and S B Pruett
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 417-423;
  • You have access
    Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine.
    B A Sorg, S Y Chen and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 424-430;
  • You have access
    Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
    R Hitzemann, Y Qian and B Hitzemann
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 431-438;
  • You have access
    Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
    C Legrand, S Mhaouty, C Rigolot and J P Maltier
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 439-449;
  • You have access
    Vascular serotonin 5-hydroxytryptamine2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries.
    R F Kauffman, J S Bean, W E Bloomquist and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 450-455;
  • You have access
    Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle.
    I Findlay
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 456-467;
  • You have access
    Guinea pig ileitis is attenuated by the leumedin N-(fluorenyl-9- methoxycarbonyl)-leucine (NPC 15199).
    M J Miller, S Chotinaruemol, H Sadowska-Krowikca, X J Zhang, J A McIntyre and D A Clark
    Journal of Pharmacology and Experimental Therapeutics July 1993, 266 (1) 468-472;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 266, Issue 1
1 Jul 1993
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics